CL vs TERN
Colgate-Palmolive Company (CL) versus Terns Pharmaceuticals Inc (TERN) — a side-by-side from cached financials, not a winner call.
Colgate-Palmolive Company (CL) is a household & personal products company listed on US.
Terns Pharmaceuticals Inc (TERN) is a biotechnology company listed on NASDAQ.
Latest reported CL revenue for 2025-12-31 was $20.38B. Net income was $2.13B. Revenue was up 1.4% from 2024-12-31 to 2025-12-31. CL currently screens at market cap $70.88B and trailing P/E 34.3.
Latest reported TERN revenue for 2022-12-31 was $0. Net income was -$60.3M. TERN currently screens at market cap $6.12B.
CL currently screens at market cap $70.88B and trailing P/E 34.3. TERN currently screens at market cap $6.12B.
Not investment advice. Open the CL and TERN stock pages for the full models.
Not investment advice.